BioSpace News Archive

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is pleased to announce that Anthony S. Crisci, Esq., CPA has joined the Company as the General Manager, Chief Compliance Officer & Corporate Counsel for all of NuGenerex’s distribution efforts, including its newly acquired eight (8) pharmacies and laboratory from Veneto Holdings, L.L.C., to lead the Company in building an end-to-end solution for pharmacy and health management services.

More than 3 million young Americans between the ages of 12 and 25 suffer from drug addiction. Overdose deaths among young people are on the rise.

Magellan Health, Inc. (NASDAQ: MGLN) announced the launch of a fully integrated health plan in Arizona, Magellan Complete Care of Arizona (MCC AZ).

National survey uncovers majority of people living with MBC say the daily stress and anxiety they experience associated with the disease can impact everything from relationships to careers, with many experiencing mental health conditions

A series of local events and career progression resources to support women living and working with a chronic disease

Alliqua BioMedical, Inc. and Adynxx, Inc. today announced that they have entered into a definitive merger agreement under which the stockholders of Adynxx would become the majority owners of Alliqua’s outstanding common stock on a fully-diluted basis.

The Delta Dental Community Care Foundation recently awarded the HACC Foundation a $50,000 grant to upgrade dental equipment in its dental clinic at the Harrisburg Campus of HACC, Central Pennsylvania’s Community College.

MassRoots (OTCQB:MSRT) based in Los Angeles, CA and a leading technology platform for medical cannabis patients and businesses, today announced that Mr. Isaac Dietrich, CEO, will present live at VirtualInvestorConferences.com on October 18, 2018, accessible via the following link.

Despite the bear market that has been upon us in recent days, marijuana companies haven’t shown weakness and have remained at a relatively strong stock price levels

According to data compiled by Arcview Market Research, in partnership with BDS Analytics, the United States’ legal cannabis market is projected to reach USD 11 Billion in consumer spending in 2018 and more than USD 23 Billion by 2023 while growing at a CAGR of 22% during the forecast period.